DEA’s suspension of McKesson Corporation Retraction

Posted in Latest News on January 19, 2017.

The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.



More Latest News

2023 Annual Long-Range Planning Meeting
December 21, 2022

The Division of Medical Quality Assurance has announced the 2023 Annual Long-Range Planning meeting. Click here for more information. Continue reading


Governor DeSantis declares State of Emergency for Subtropical Storm Nicole
November 7, 2022

On Monday, November 7, 2022, Governor Ron DeSantis declared a State of Emergency to prepare for Subtropical Storm Nicole. Continue reading